Page last updated: 2024-08-23

raloxifene hydrochloride and Epistaxis

raloxifene hydrochloride has been researched along with Epistaxis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albiñana, V; Bernabéu, C; Bernabeu-Herrero, ME; Botella, LM; Zarrabeitia, R	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Epistaxis

Article	Year
Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Thrombosis and haemostasis, 2010, Volume: 103, Issue:3 Topics: Activin Receptors, Type II; Aged; Antigens, CD; Cell Line; Endoglin; Endothelial Cells; Endothelium, Vascular; Epistaxis; Estrogens; Female; Humans; Menopause; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Receptors, Cell Surface; Selective Estrogen Receptor Modulators; Telangiectasia, Hereditary Hemorrhagic; Transcription, Genetic	2010

Article

Year

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.

Thrombosis and haemostasis, 2010, Volume: 103, Issue:3

Topics: Activin Receptors, Type II; Aged; Antigens, CD; Cell Line; Endoglin; Endothelial Cells; Endothelium, Vascular; Epistaxis; Estrogens; Female; Humans; Menopause; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Receptors, Cell Surface; Selective Estrogen Receptor Modulators; Telangiectasia, Hereditary Hemorrhagic; Transcription, Genetic

2010